During the COVID-19 pandemic, biopharmaceutical companies proactively interrupted face-to-face interactions between their representatives and physicians, in order to protect patients, healthcare professionals and their own employees have replaced in-office visits and face-to-face congresses with digital innovation in the pharma – virtual meetings, webinars, etc. Overworked healthcare professionals are under high pressure, and a lot of […]
